Litcius/Paper detail

Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study

Juan P. Frías, Stanley H. Hsia, Sarah Eyde, Rong Liu, Xiaosu Ma, Маниге Кониг, Christof Kazda, Kieren J. Mather, Axel Haupt, Edward Pratt, Deborah A. Robins

2023The Lancet159 citationsDOI

Topics & Concepts

MedicineType 2 diabetesInternal medicineDiabetes mellitusEndocrinologyDiabetes Treatment and ManagementBariatric Surgery and OutcomesHyperglycemia and glycemic control in critically ill and hospitalized patients
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study | Litcius